Springer Nature is making SARS-CoV-2 and COVID-19 research free. View research | View latest news | Sign up for updates

Leukemogenesis of Adult T-Cell Leukemia

  • 63 Accesses

  • 17 Citations

Abstract

Adult T-cell leukemia (ATL) is one of the most aggressive hematologic malignancies and is caused by human T-cell leukemia virus type I (HTLV-I). Tax, encoded by the HTLV-I pX region, has been recognized by its pleiotropic actions as a critical accessory protein playing a central role in leukemogenesis. However, fresh ATL cells frequently lose Tax protein expression via several mechanisms, such as genetic and epigenetic changes in the provirus. Furthermore, there is a long latency period before the onset of ATL, indicating the multistep mechanisms of leukemogenesis.Therefore, additional factors, including other viral proteins, genetic and epigenetic changes of the host genome, and alterations in the gene expression and immune systems of the host cells, may be implicated in ATL leukemogenesis. This review summarizes recent advances in the understanding of ATL leukemogenesis.

This is a preview of subscription content, log in to check access.

References

  1. 1.

    Takatsuki K, Uchiyama T, Sagawa K, Yodoi J. Adult T-cell leukemia in Japan. In: Seno S, Takaku F, Irino S, eds.Topics in Hematology, the 16th International Congress of Hematology, 1976, Kyoto, Japan. Amsterdam, the Netherlands: Excerpta Medica; 1977:73–77.

  2. 2.

    Uchiyama T, Yodoi J, Sagawa K, Takatsuki K, Uchino H. Adult T-cell leukemia: clinical and hematologic features of 16 cases.Blood. 1977;50:481–492.

  3. 3.

    Poiesz BJ, Ruscetti FW, Gazdar AF, Bunn PA, Minna JD, Gallo RC. Detection and isolation of type C retrovirus particles from fresh and cultured lymphocytes of a patient with cutaneous T-cell lymphoma.Proc Natl Acad Sci U S A. 1980;77:7415–7419.

  4. 4.

    Hinuma Y, Nagata K, Hanaoka M, et al. Adult T-cell leukemia: antigen in an ATL cell line and detection of antibodies to the antigen in human sera.Proc Natl Acad Sci U S A. 1981;78:6476–6480.

  5. 5.

    Matsuoka M. Human T-cell leukemia virus type I and adult T-cell leukemia.Oncogene. 2003;22:5131–5140.

  6. 6.

    Seiki M, Hattori S, Hirayama Y, Yoshida M. Human adult T-cell leukemia virus: complete nucleotide sequence of the provirus genome integrated in leukemia cell DNA.Proc Natl Acad Sci U SA. 1983;80:3618–3622.

  7. 7.

    Aldovini A, De Rossi A, Feinberg MB, Wong-Staal F, Franchini G. Molecular analysis of a deletion mutant provirus of type I human T-cell lymphotropic virus: evidence for a doubly spliced x-lor mRNA.Proc Natl Acad Sci U S A. 1986;83:38–42.

  8. 8.

    Albrecht B, Lairmore MD. Critical role of human T-lymphotropic virus type 1 accessory proteins in viral replication and pathogenesis.Microbiol Mol Biol Rev. 2002;66:396–406.

  9. 9.

    Yoshida M. Multiple viral strategies of HTLV-1 for dysregulation of cell growth control.Annu Rev Immunol. 2001;19:475–496.

  10. 10.

    Fujii M, Iwai K, Oie M, et al. Activation of oncogenic transcription factor AP-1 in T-cells infected with human T-cell leukemia virus type 1.AIDS Res Hum Retroviruses. 2000;16:1603–1606.

  11. 11.

    Mori N, Morishita M, Tsukazaki T, et al. Human T-cell leukemia virus type I oncoprotein Tax represses Smad-dependent transforming growth factor β signaling through interaction with CREBbinding protein/p300.Blood. 2001;97:2137–2144.

  12. 12.

    Lee DK, Kim BC, Brady JN, Jeang KT, Kim SJ. Human T-cell lymphotropic virus type 1 Tax inhibits transforming growth factor-β signaling by blocking the association of Smad proteins with Smadbinding element.J Biol Chem. 2002;277:33766–33775.

  13. 13.

    Ding W, Albrecht B, Luo R, et al. Endoplasmic reticulum andcis-Golgi localization of human T-lymphotropic virus type 1 p12(I): association with calreticulin and calnexin.J Virol. 2001;75:7672–7682.

  14. 14.

    Collins ND, Newbound GC, Albrecht B, Beard JL, Ratner L, Lairmore MD. Selective ablation of human T-cell lymphotropic virus type 1 p12I reduces viral infectivity in vivo.Blood. 1998;91:4701–4707.

  15. 15.

    Albrecht B, Collins ND, Burniston MT, et al. Human T-lymphotropic virus type 1 open reading frame I p12(I) is required for efficient viral infectivity in primary lymphocytes.J Virol. 2000;74:9828–9835.

  16. 16.

    Ding W, Albrecht B, Kelley RE, et al. Human T-cell lymphotropic virus type 1 p12(I) expression increases cytoplasmic calcium to enhance the activation of nuclear factor of activated T-cells.J Virol. 2002;76:10374–10382.

  17. 17.

    Bartoe JT, Albrecht B, Collins ND, et al. Functional role of pX open reading frame II of human T-lymphotropic virus type 1 in maintenance of viral loads in vivo.J Virol. 2000;74:1094–1100.

  18. 18.

    Edlich RF, Arnette JA, Williams FM. Global epidemic of human T-cell lymphotropic virus type-I (HTLV-I).J Emerg Med. 2000;18:109–119.

  19. 19.

    Arisawa K, Soda M, Endo S, et al. Evaluation of adult T-cell leukemia/lymphoma incidence and its impact on non-Hodgkin lymphoma incidence in southwestern Japan.Int J Cancer. 2000;85:319–324.

  20. 20.

    Takatsuki K, Yamaguchi K, Matsuoka M. ATL and HTLV-I-related diseases. In: Takatsuki K, ed.Adult T-Cell Leukemia. New York, NY: Oxford University Press; 1994:1–27.

  21. 21.

    Hanchard B. Adult T-cell leukemia/lymphoma in Jamaica: 1986–1995.J Acquir Immune Defic Syndr Hum Retrovirol. 1996;13(suppl 1):S20-S25.

  22. 22.

    Okamoto T, Ohno Y, Tsugane S, et al. Multi-step carcinogenesis model for adult T-cell leukemia.Jpn J Cancer Res. 1989;80:191–195.

  23. 23.

    Seiki M, Eddy R, Shows TB, Yoshida M. Nonspecific integration of the HTLV provirus genome into adult T-cell leukaemia cells.Nature. 1984;309:640–642.

  24. 24.

    Etoh K, Yamaguchi K, Tokudome S, et al. Rapid quantification of HTLV-I provirus load: detection of monoclonal proliferation of HTLV-I-infected cells among blood donors.Int J Cancer. 1999;81:859–864.

  25. 25.

    Iga M, Okayama A, Stuver S, et al. Genetic evidence of transmission of human T-cell lymphotropic virus type 1 between spouses.J Infect Dis. 2002;185:691–695.

  26. 26.

    Etoh K, Tamiya S, Yamaguchi K, et al. Persistent clonal proliferation of human T-lymphotropic virus type I-infected cells in vivo.Cancer Res. 1997;57:4862–4867.

  27. 27.

    Cavrois M, Leclercq I, Gout O, Gessain A, Wain-Hobson S, Wattel E. Persistent oligoclonal expansion of human T-cell leukemia virus type 1-infected circulating cells in patients with tropical spastic paraparesis/HTLV-1 associated myelopathy.Oncogene. 1998;17:77–82.

  28. 28.

    Sakashita A, Hattori T, Miller CW, et al. Mutations of the p53 gene in adult T-cell leukemia.Blood. 1992;79:477–480.

  29. 29.

    Cesarman E, Chadburn A, Inghirami G, Gaidano G, Knowles DM. Structural and functional analysis of oncogenes and tumor suppressor genes in adult T-cell leukemia/lymphoma shows frequent p53 mutations.Blood. 1992;80:3205–3216.

  30. 30.

    Nishimura S, Asou N, Suzushima H, et al. p53 gene mutation and loss of heterozygosity are associated with increased risk of disease progression in adult T-cell leukemia.Leukemia. 1995;9:598–604.

  31. 31.

    Hatta Y, Hirama T, Miller CW, Yamada Y, Tomonaga M, Koeffler HP. Homozygous deletions of the p15 (MTS2) and p16 (CDKN2/MTS1) genes in adult T-cell leukemia.Blood. 1995;85:2699–2704.

  32. 32.

    Uchida T, Kinoshita T, Watanabe T, et al. The CDKN2 gene alterations in various types of adult T-cell leukaemia.Br J Haematol. 1996;94:665–670.

  33. 33.

    Nosaka K, Maeda M, Tamiya S, Sakai T, Mitsuya H, Matsuoka M. Increasing methylation of the CDKN2A gene is associated with the progression of adult T-cell leukemia.Cancer Res. 2000;60:1043–1048.

  34. 34.

    Morosetti R, Kawamata N, Gombart AF, et al. Alterations of the p27KIP1 gene in non-Hodgkin’s lymphomas and adult T-cell leukemia/lymphoma.Blood. 1995;86:1924–1930.

  35. 35.

    Hatta Y, Yamada Y, Tomonaga M, Koeffler HP. Extensive analysis of the retinoblastoma gene in adult T-cell leukemia/lymphoma (ATL).Leukemia. 1997;11:984–989.

  36. 36.

    Takeuchi S, Takeuchi N, Tsukasaki K, et al. Mutations in the retinoblastoma-related gene RB2/p130 in adult T-cell leukaemia/lymphoma.Leuk Lymphoma. 2003;44:699–701.

  37. 37.

    Tamiya S, Etoh K, Suzushima H, Takatsuki K, Matsuoka M. Mutation of CD95 (Fas/Apo-1) gene in adult T-cell leukemia cells.Blood. 1998;91:3935–3942.

  38. 38.

    Maeda T, Yamada Y, Moriuchi R, et al. Fas gene mutation in the progression of adult T-cell leukemia.J Exp Med. 1999;189:1063–1071.

  39. 39.

    Miyamoto Y, Yamaguchi K, Nishimura H, et al. Familial adult T-cell leukemia.Cancer. 1985;55:181–185.

  40. 40.

    Tsukasaki K, Miller CW, Kubota T, et al. Tumor necrosis factor β polymorphism associated with increased susceptibility to development of adult T-cell leukemia/lymphoma in human T-lymphotropic virus type 1 carriers.Cancer Res. 2001;61:3770–3774.

  41. 41.

    Wano Y, Feinberg M, Hosking JB, Bogerd H, Greene WC. Stable expression of the Tax gene of type I human T-cell leukemia virus in human T-cells activates specific cellular genes involved in growth.Proc Natl Acad Sci U S A. 1988;85:9733–9737.

  42. 42.

    Muraoka O, Kaisho T, Tanabe M, Hirano T. Transcriptional activation of the interleukin-6 gene by HTLV-1 p40tax through an NFkappa B-like binding site.Immunol Lett. 1993;37:159–165.

  43. 43.

    Azimi N, Brown K, Bamford RN, Tagaya Y, Siebenlist U, Waldmann TA. Human T-cell lymphotropic virus type I Tax protein trans-activates interleukin 15 gene transcription through an NF-κB site.Proc Natl Acad Sci U S A. 1998;95:2452–2457.

  44. 44.

    Himes SR, Coles LS, Katsikeros R, Lang RK, Shannon MF. HTLV-1 tax activation of the GM-CSF and G-CSF promoters requires the interaction of NF-κB with other transcription factor families.Oncogene. 1993;8:3189–3197.

  45. 45.

    Ballard DW, Bohnlein E, Lowenthal JW, Wano Y, Franza BR, Greene WC. HTLV-I tax induces cellular proteins that activate the kappa B element in the IL-2 receptor alpha gene.Science. 1988;241:1652–1655.

  46. 46.

    Fujii M, Sassone-Corsi P, Verma IM. c-fos promoter trans-activation by the tax1 protein of human T-cell leukemia virus type I.Proc Natl Acad Sci U S A. 1988;85:8526–8530.

  47. 47.

    Fujii M, Niki T, Mori T, et al. HTLV-1 Tax induces expression of various immediate early serum responsive genes.Oncogene. 1991;6:1023–1029.

  48. 48.

    Cereseto A, Diella F, Mulloy JC, et al. p53 functional impairment and high p21waf1/cip1 expression in human T- cell lymphotropic/ leukemia virus type I-transformed T-cells.Blood. 1996;88:1551–1560.

  49. 49.

    Akagi T, Ono H, Shimotohno K. Expression of cell-cycle regulatory genes in HTLV-I infected T-cell lines: possible involvement ofLeukemogenesis of ATL 319 Tax1 in the altered expression of cyclin D2, p18Ink4 and p21Waf1/ Cip1/Sdi1.Oncogene. 1996;12:1645–1652.

  50. 50.

    Iwanaga R, Ohtani K, Hayashi T, Nakamura M. Molecular mechanism of cell cycle progression induced by the oncogene product Tax of human T-cell leukemia virus type I.Oncogene. 2001;20:2055–2067.

  51. 51.

    Tsukahara T, Kannagi M, Ohashi T, et al. Induction of Bcl-xL expression by human T-cell leukemia virus type 1 Tax through NF-κB in apoptosis-resistant T-cell transfectants with Tax.J Virol. 1999;73:7981–7987.

  52. 52.

    Mamane Y, Sharma S, Grandvaux N, Hernandez E, Hiscott J. IRF-4 activities in HTLV-I-induced T-cell leukemogenesis.J Interferon Cytokine Res. 2002;22:135–143.

  53. 53.

    Hayashibara T, Yamada Y, Mori N, et al. Possible involvement of aryl hydrocarbon receptor (AhR) in adult T-cell leukemia (ATL) leukemogenesis: constitutive activation of AhR in ATL.Biochem Biophys Res Commun. 2003;300:128–134.

  54. 54.

    Jeang KT, Widen SG, Semmes OJ. 4th,Wilson SH. HTLV-I transactivator protein,Tax, is a trans-repressor of the human beta-polymerase gene.Science. 1990;247:1082–1084.

  55. 55.

    Lemasson I, Robert-Hebmann V, Hamaia S, Duc Dodon M, Gazzolo L, Devaux C. Transrepression of lck gene expression by human T-cell leukemia virus type 1-encoded p40tax.J Virol. 1997;71:1975–1983.

  56. 56.

    Suzuki T, Uchida-Toita M, Yoshida M. Tax protein of HTLV-1 inhibits CBP/p300-mediated transcription by interfering with recruitment of CBP/p300 onto DNA element of E-box or p53 binding site.Oncogene. 1999;18:4137–4143.

  57. 57.

    Ruckes T, Saul D, Van Snick J, Hermine O, Grassmann R. Autocrine antiapoptotic stimulation of cultured adult T-cell leukemia cells by overexpression of the chemokine I-309.Blood. 2001;98:1150–1159.

  58. 58.

    Fujii K, Ishimaru F, Nakase K, et al. Over-expression of short isoforms of Helios in patients with adult T-cell leukaemia/lymphoma.BrJ Haematol. 2003;120:986–989.

  59. 59.

    Kiyokawa T, Yamaguchi K, Takeya M, et al. Hypercalcemia and osteoclast proliferation in adult T-cell leukemia.Cancer. 1987;59:1187–1191.

  60. 60.

    Arai F, Miyamoto T, Ohneda O, et al. Commitment and differentiation of osteoclast precursor cells by the sequential expression of c-Fms and receptor activator of nuclear factor κB (RANK) receptors.J Exp Med. 1999;190:1741–1754.

  61. 61.

    Nosaka K, Miyamoto T, Sakai T, Mitsuya H, Suda T, Matsuoka M. Mechanism of hypercalcemia in adult T-cell leukemia: overexpression of receptor activator of nuclear factor κB ligand on adult T-cell leukemia cells.Blood. 2002;99:634–640.

  62. 62.

    Wano Y, Hattori T, Matsuoka M, et al. Interleukin 1 gene expression in adult T-cell leukemia.J Clin Invest. 1987;80:911–916.

  63. 63.

    Niitsu Y, Urushizaki Y, Koshida Y, et al. Expression of TGF-βgene in adult T-cell leukemia.Blood. 1988;71:263–266.

  64. 64.

    Watanabe T, Yamaguchi K, Takatsuki K, Osame M, Yoshida M. Constitutive expression of parathyroid hormone-related protein gene in human T-cell leukemia virus type 1 (HTLV-1) carriers and adult T-cell leukemia patients that can be trans-activated by HTLV-1 tax gene.J Exp Med. 1990;172:759–765.

  65. 65.

    Harhaj EW, Good L, Xiao G, Sun SC. Gene expression profiles in HTLV-I-immortalized T-cells: deregulated expression of genes involved in apoptosis regulation.Oncogene. 1999;18:1341–1349.

  66. 66.

    de La Fuente C, Deng L, Santiago F, Arce L, Wang L, Kashanchi F. Gene expression array of HTLV type 1-infected T-cells: up-regulation of transcription factors and cell cycle genes.AIDS Res Hum Retroviruses. 2000;16:1695–1700.

  67. 67.

    Ng PW, Iha H, Iwanaga Y, et al. Genome-wide expression changes induced by HTLV-1 Tax: evidence for MLK-3 mixed lineage kinase involvement in Tax-mediated NF-κB activation.Oncogene. 2001;20:4484–4496.

  68. 68.

    Pise-Masison CA, Radonovich M, Mahieux R, et al. Transcription profile of cells infected with human T-cell leukemia virus type I compared with activated lymphocytes.Cancer Res. 2002;62:3562–3571.

  69. 69.

    Wodarz D, Hall SE, Usuku K, et al. Cytotoxic T-cell abundance and virus load in human immunodeficiency virus type 1 and human T-cell leukaemia virus type 1.Proc R Soc Lond B Biol Sci. 2001;268:1215–1221.

  70. 70.

    Borg A, Yin JA, Johnson PR, Tosswill J, Saunders M, Morris D. Successful treatment of HTLV-1-associated acute adult T-cell leukaemia lymphoma by allogeneic bone marrow transplantation.Br J Haematol. 1996;94:713–715.

  71. 71.

    Utsunomiya A, Miyazaki Y, Takatsuka Y, et al. Improved outcome of adult T-cell leukemia/lymphoma with allogeneic hematopoietic stem cell transplantation.Bone Marrow Transplant. 2001;27:15–20.

  72. 72.

    Hoshida Y, Li T, Dong Z, et al. Lymphoproliferative disorders in renal transplant patients in Japan.Int J Cancer. 2001;91:869–875.

  73. 73.

    Yashiki S, Fujiyoshi T, Arima N, et al. HLA-A*26, HLA-B*4002, HLA-B*4006, and HLA-B*4801 alleles predispose to adult T-cell leukemia: the limited recognition of HTLV type 1 Tax peptide anchor motifs and epitopes to generate anti-HTLV type 1 Tax CD8+ cytotoxic T lymphocytes.AIDS Res Hum Retroviruses. 2001;17:1047–1061.

  74. 74.

    Jacobson S, Shida H, McFarlin DE, Fauci AS, Koenig S. Circulating CD8+ cytotoxic T lymphocytes specific for HTLV-I pX in patients with HTLV-I associated neurological disease.Nature. 1990;348:245–248.

  75. 75.

    Kannagi M, Harada S, Maruyama I, et al. Predominant recognition of human T-cell leukemia virus type I (HTLV-I) pX gene products by human CD8+ cytotoxic T-cells directed against HTLV-I-infected cells.Int Immunol. 1991;3:761–767.

  76. 76.

    Tamiya S, Matsuoka M, Etoh K, et al. Two types of defective human T-lymphotropic virus type I provirus in adult T-cell leukemia.Blood. 1996;88:3065–3073.

  77. 77.

    Furukawa Y, Kubota R, Tara M, Izumo S, Osame M. Existence of escape mutant in HTLV-Itax during the development of adult T-cell leukemia.Blood. 2001;97:987–993.

  78. 78.

    Koiwa T, Hamano-Usami A, Ishida T, et al. 5′-long terminal repeatselective CpG methylation of latent human T-cell leukemia virus type 1 provirus in vitro and in vivo.J Virol. 2002;76:9389–9397.

  79. 79.

    Kibler KV, Jeang KT. Taxing the cellular capacity for repair: human T-cell leukemia virus type 1, DNA damage, and adult T-cell leukemia.J Natl Cancer Inst. 1999;91:903–904.

  80. 80.

    White JD, Zaknoen SL, Kasten-Sportes C, et al. Infectious complications and immunodeficiency in patients with human T-cell lymphotropic virus I-associated adult T-cell leukemia/lymphoma.Cancer. 1995;75:1598–1607.

  81. 81.

    Katsuki T, Katsuki K, Imai J, Hinuma Y. Immune suppression in healthy carriers of adult T-cell leukemia retrovirus (HTLV-I): impairment of T-cell control of Epstein-Barr virus-infected B-cells.Jpn J Cancer Res. 1987;78:639–642.

  82. 82.

    Sadahira Y, Nishihara H, Shimizu M, et al. Epstein-Barr virusassociated Hodgkin’s disease in HTLV-I seropositive patients: a report of two cases.Pathol Int. 1998;48:67–73.

  83. 83.

    Welles SL, Tachibana N, Okayama A, et al. Decreased reactivity to PPD among HTLV-I carriers in relation to virus and hematologic status.Int J Cancer. 1994;56:337–340.

  84. 84.

    Yasunaga J, Sakai T, Nosaka K, et al. Impaired production of naive T lymphocytes in human T-cell leukemia virus type I-infected individuals: its implications in the immunodeficient state.Blood. 2001;97:3177–3183.

  85. 85.

    Nagai M, Brennan MB, Sakai JA, Mora CA, Jacobson S. CD8+T-cells are an in vivo reservoir for human T-cell lymphotropic virus type I.Blood. 2001;98:1858–1861.

  86. 86.

    Hanon E, Stinchcombe JC, Saito M, et al. Fratricide among CD8+T lymphocytes naturally infected with human T-cell lymphotropic virus type I.Immunity. 2000;13:657–664.

  87. 87.

    Kannagi M, Ohashi T, Hanabuchi S, et al. Immunological aspects of rat models of HTLV type 1-infected T lymphoproliferative disease.AIDS Res Hum Retroviruses. 2000;16:1737–1740.

  88. 88.

    Ohshima K, Haraoka S, Yoshioka S, et al. Mutation analysis of mitotic checkpoint genes (hBUB1 and hBUBR1) and microsatellite instability in adult T-cell leukemia/lymphoma.Cancer Lett. 2000;158:141–150.

  89. 89.

    Yamada Y, Sugawara K, Hata T, et al. Interleukin-15 (IL-15) can replace the IL-2 signal in IL-2-dependent adult T-cell leukemia (ATL) cell lines: expression of IL-15 receptor α on ATL cells.Blood. 1998;91:4265–4272.

  90. 90.

    Yoshie O, Fujisawa R, Nakayama T, et al. Frequent expression of CCR4 in adult T-cell leukemia and human T-cell leukemia virus type 1-transformed T-cells.Blood. 2002;99:1505–1511.

  91. 91.

    Hasegawa H, Nomura T, Kohno M, et al. Increased chemokine receptor CCR7/EBI1 expression enhances the infiltration of lymphoid organs by adult T-cell leukemia cells.Blood. 2000;95:30–38.

  92. 92.

    Arai M, Ohashi T, Tsukahara T, et al. Human T-cell leukemia virus type 1 Tax protein induces the expression of lymphocyte chemoattractant SDF-1/PBSF.Virology. 1998;241:298–303.

  93. 93.

    Mori N, Nunokawa Y, Yamada Y, Ikeda S, Tomonaga M, Yamamoto N. Expression of human inducible nitric oxide synthase gene in T-cell lines infected with human T-cell leukemia virus type-I and primary adult T-cell leukemia cells.Blood. 1999;94:2862–2870.

  94. 94.

    Mori N, Sato H, Hayashibara T, et al. Human T-cell leukemia virus type I Tax transactivates the matrix metalloproteinase-9 gene: potential role in mediating adult T-cell leukemia invasiveness.Blood. 2002;99:1341–1349.

  95. 95.

    Miura S, Ohtani K, Numata N, et al. Molecular cloning and characterization of a novel glycoprotein, gp34, that is specifically induced by the human T-cell leukemia virus type I transactivator p40tax.Mol Cell Biol. 1991;11:1313–1325.

  96. 96.

    Imura A, Hori T, Imada K, et al. OX40 expressed on fresh leukemic cells from adult T-cell leukemia patients mediates cell adhesion to vascular endothelial cells: implication for the possible involvement of OX40 in leukemic cell infiltration.Blood. 1997;89:2951–2958.

  97. 97.

    Brauweiler A, Garrus JE, Reed JC, Nyborg JK. Repression of bax gene expression by the HTLV-1 Tax protein: implications for suppression of apoptosis in virally infected cells.Virology. 1997;231:135–140.

Download references

Author information

Correspondence to Jun-ichirou Yasunaga or Masao Matsuoka.

About this article

Cite this article

Yasunaga, J., Matsuoka, M. Leukemogenesis of Adult T-Cell Leukemia. Int J Hematol 78, 312–320 (2003). https://doi.org/10.1007/BF02983555

Download citation

Key words

  • Adult T-cell leukemia
  • Human T-cell leukemia virus type I
  • Multistep leukemogenesis
  • Provirus
  • Clonal expansion